Xun Bao

1.4k total citations
42 papers, 953 citations indexed

About

Xun Bao is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xun Bao has authored 42 papers receiving a total of 953 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 19 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xun Bao's work include Cancer, Hypoxia, and Metabolism (8 papers), Glioma Diagnosis and Treatment (6 papers) and PARP inhibition in cancer therapy (5 papers). Xun Bao is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), Glioma Diagnosis and Treatment (6 papers) and PARP inhibition in cancer therapy (5 papers). Xun Bao collaborates with scholars based in United States, China and United Kingdom. Xun Bao's co-authors include Jing Li, Jianmei Wu, Nader Sanai, Seongho Kim, Brian Shuch, Ranjit S. Bindra, Peter M. Glazer, Parker L. Sulkowski, Sebastian Oeck and Jun Jiang and has published in prestigious journals such as Nature, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Xun Bao

40 papers receiving 947 citations

Peers

Countries citing papers authored by Xun Bao

Since Specialization

Citations

This map shows the geographic impact of Xun Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xun Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xun Bao more than expected).

Fields of papers citing papers by Xun Bao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xun Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xun Bao. The network helps show where Xun Bao may publish in the future.

Co-authorship network of co-authors of Xun Bao

This figure shows the co-authorship network connecting the top 25 collaborators of Xun Bao. A scholar is included among the top collaborators of Xun Bao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xun Bao. Xun Bao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacodynamic determinants of mitochondrial one-carbon flux and serine hydroxymethyltransferase inhibition in human tumors 2025 ·Drug Metabolism and Disposition ·(unknown), (unknown), Xun Bao, (unknown), (unknown), (unknown), Jing Li, Seongho Kim, Charles E. Dann, Aleem Gangjee, Zhanjun Hou, Larry H. Matherly	0
2	1000MO A phase I/II, open-label study of the novel checkpoint IGSF8 inhibitor GV20-0251 in patients with advanced solid tumors 2024 ·Annals of Oncology ·(unknown), (unknown), (unknown), Patricia LoRusso, Janice M. Mehnert, Alexander I. Spira, (unknown), Omid Hamid, (unknown), Karim A. Benhadji, Leila Alland, Xi Hu, Hong‐Ping Xiao, Xun Bao, (unknown), Yubao Gong, Xuesheng Liu	2
3	SHMT2 reduces fatty liver but is necessary for liver inflammation and fibrosis in mice 2024 ·Communications Biology ·Guohua Chen, Guoli Zhou, Lidong Zhai, Xun Bao, Nivedita Tiwari, Jing Li, Emilio P. Mottillo, (unknown)	6
4	Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer 2024 ·Molecular Cancer Therapeutics ·Adrianne Wallace-Povirk, (unknown), (unknown), Xun Bao, (unknown), (unknown), (unknown), Jennifer Wong-Roushar, Seongho Kim, Lisa Polin, Jing Li, (unknown), Charles E. Dann, Aleem Gangjee, Zhanjun Hou, Larry H. Matherly	8
5	Multitargeted 6-Substituted Thieno[2,3-d]pyrimidines as Folate Receptor-Selective Anticancer Agents that Inhibit Cytosolic and Mitochondrial One-Carbon Metabolism 2023 ·ACS Pharmacology & Translational Science ·(unknown), Jennifer Wong-Roushar, Adrianne Wallace-Povirk, (unknown), (unknown), (unknown), (unknown), (unknown), Xun Bao, Seongho Kim, Jing Li, Zhanjun Hou, Larry H. Matherly, Charles E. Dann, Aleem Gangjee	6
6	Abstract 4902: Mitochondrial and cytosolic folylpolyglutamate synthetase in one-carbon metabolism and anti-tumor efficacy of mitochondrial-targeted antifolates 2023 ·Cancer Research ·(unknown), (unknown), (unknown), (unknown), Xun Bao, (unknown), Charles E. Dann, Aleem Gangjee, Larry H. Matherly, Zhanjun Hou	1
7	Mechanistic Modeling of Central Nervous System Pharmacokinetics and Target Engagement of HER2 Tyrosine Kinase Inhibitors to Inform Treatment of Breast Cancer Brain Metastases 2022 ·Clinical Cancer Research ·Jing Li, Jun Jiang, Xun Bao, Vineet Kumar, Stephen C. Alley, Scott Peterson, Anthony Lee	19
8	A Phase 0 Trial of Ceritinib in Patients with Brain Metastases and Recurrent Glioblastoma 2021 ·Clinical Cancer Research ·Shwetal Mehta, Roberto Fiorelli, Xun Bao, (unknown), (unknown), Seongho Kim, Wonsuk Yoo, Jing Li, Nader Sanai	15
9	Discovery of 6-substituted thieno[2,3-d]pyrimidine analogs as dual inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase in de novo purine nucleotide biosynthesis in folate receptor expressing human tumors 2021 ·Bioorganic & Medicinal Chemistry ·Adrianne Wallace-Povirk, (unknown), Jennifer Wong-Roushar, (unknown), (unknown), Zhanjun Hou, Xun Bao, (unknown), Jing Li, Seongho Kim, Charles E. Dann, Larry H. Matherly, Aleem Gangjee	11
10	Oncometabolites suppress DNA repair by disrupting local chromatin signalling 2020 ·Nature ·Parker L. Sulkowski, Sebastian Oeck, (unknown), (unknown), (unknown), Yanfeng Liu, (unknown), Xun Bao, Jing Li, Brian Shuch, Megan C. King, Ranjit S. Bindra, Peter M. Glazer	200
11	A Phase 0 Trial of Ribociclib in Recurrent Glioblastoma Patients Incorporating a Tumor Pharmacodynamic- and Pharmacokinetic-Guided Expansion Cohort 2019 ·Clinical Cancer Research ·An‐Chi Tien, Jing Li, Xun Bao, (unknown), Seongho Kim, Shwetal Mehta, Nader Sanai	55
12	Amino acid-linked platinum(II) compounds: non-canonical nucleoside preferences and influence on glycosidic bond stabilities 2019 ·JBIC Journal of Biological Inorganic Chemistry ·(unknown), Chenchen He, (unknown), (unknown), Xun Bao, Jun Jiang, Zhihua Yang, M. T. Rodgers, Christine S. Chow	7
13	Quantitative Profiling of Oncometabolites in Frozen and Formalin-Fixed Paraffin-Embedded Tissue Specimens by Liquid Chromatography Coupled with Tandem Mass Spectrometry 2019 ·Scientific Reports ·Xun Bao, Jianmei Wu, Brian Shuch, Patricia LoRusso, Ranjit S. Bindra, Jing Li	8
14	Determination of total and unbound ribociclib in human plasma and brain tumor tissues using liquid chromatography coupled with tandem mass spectrometry 2019 ·Journal of Pharmaceutical and Biomedical Analysis ·Xun Bao, Jianmei Wu, Nader Sanai, Jing Li	25
15	Nano-delivery of RAD6 /Translesion Synthesis Inhibitor SMI#9 for Triple-negative Breast Cancer Therapy 2018 ·Molecular Cancer Therapeutics ·Nadia Saadat, Fangchao Liu, Brittany Haynes, Pratima Nangia‐Makker, Xun Bao, Jing Li, Lisa Polin, Smiti Gupta, Guangzhao Mao, Malathy P.V. Shekhar	15
16	Strategy for Tumor-Selective Disruption of Androgen Receptor Function in the Spectrum of Prostate Cancer 2018 ·Clinical Cancer Research ·Rayna Rosati, Lisa Polin, Charles Ducker, Jing Li, Xun Bao, (unknown), Seongho Kim, (unknown), Martha J. Larsen, (unknown), Yanfang Huang, Benjamin L. Kidder, Andrew M. Fribley, Janice Saxton, Hiroki Kakuta, Peter E. Shaw, Manohar Ratnam	16
17	Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair 2018 ·Nature Genetics ·Parker L. Sulkowski, Ranjini K. Sundaram, Sebastian Oeck, Christopher D. Corso, Yanfeng Liu, Seth Noorbakhsh, Monica Niger, Marta Boeke, Daiki Ueno, (unknown), Xun Bao, Jing Li, Brian Shuch, Ranjit S. Bindra, Peter M. Glazer	155
18	Quantitative and Mechanistic Understanding of AZD1775 Penetration across Human Blood–Brain Barrier in Glioblastoma Patients Using an IVIVE–PBPK Modeling Approach 2017 ·Clinical Cancer Research ·Jing Li, Jianmei Wu, Xun Bao, Norissa Honea, Youming Xie, Seongho Kim, Alex Sparreboom, Nader Sanai	45
19	An aqueous normal-phase chromatography coupled with tandem mass spectrometry method for determining unbound brain-to-plasma concentration ratio of AZD1775, a Wee1 kinase inhibitor, in patients with glioblastoma 2016 ·Journal of Chromatography B ·Jianmei Wu, Nader Sanai, Xun Bao, Patricia LoRusso, Jing Li	11
20	Gold nanoparticle conjugated Rad6 inhibitor induces cell death in triple negative breast cancer cells by inducing mitochondrial dysfunction and PARP-1 hyperactivation: Synthesis and characterization 2015 ·Nanomedicine Nanotechnology Biology and Medicine ·Brittany Haynes, Yanhua Zhang, (unknown), Jing Li, Sarah A. Petit, Hend Kothayer, Xun Bao, Andrew D. Westwell, Guangzhao Mao, Malathy P.V. Shekhar	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact